HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Translational Research: Bridging the gap between laboratory findings and clinical applications.

Translational Research: Bridging the gap between laboratory findings and clinical applications.

Translational research is the bridge between laboratory science and clinical practice, enabling the rapid application of discoveries from the bench to the bedside. It involves converting insights from cancer biology, genetics, and molecular pathways into new diagnostic tools, treatment strategies, and prevention methods that can be tested in clinical trials. Translational research is focused on improving clinical trial design, identifying biomarkers that predict treatment responses, and enhancing patient recruitment strategies to ensure diverse representation in studies. By refining these aspects, translational research accelerates the process of developing innovative, evidence-based treatments that can significantly improve patient outcomes. This approach emphasizes collaboration between researchers, clinicians, and the healthcare system to bring cutting-edge science directly to those in need, driving meaningful improvements in cancer care.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp